Clinical Trials › NCT05286242
Active, Not Recruiting
Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients
Sponsored by Yale University
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 400
Target enrollment
1
U.S. states
Feb 2021
Start date
Jun 2026
Expected completion
Interventions / Treatments
COVID19 vaccine
Conditions studied
Multiple Sclerosis
Where this trial is running (1 site)
Connecticut1 site
New Haven
MS centers in Connecticut
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View Connecticut centersCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
